As of 2025-07-03, the Intrinsic Value of Molecule Holdings Inc (MLCL.CN) is -0.22 CAD. This MLCL.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Molecule Holdings Inc is -4,436.57%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Molecule Holdings Inc (MLCL.CN) is overvalued by 4,436.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.22 - -0.22 | -0.22 | -4,436.57% |
| P/E | (0.07) - (0.14) | (0.07) | -1487.7% |
| DDM - Stable | (0.09) - (0.26) | (0.17) | -3595.4% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 0.48 |
| Beta | 1.39 |
| Outstanding shares (mil) | 95.38 |
| Enterprise Value (mil) | 5.93 |
| Market risk premium | 5.10% |
| Cost of Equity | 28.56% |
| Cost of Debt | 5.00% |
| WACC | 5.78% |